Lawrence Ho's Family Office Black Spade Capital Makes its First Move in the Medical IT Space via My Platform
HONG KONG, Jun 10, 2020 - (ACN Newswire) - Black Spade Capital Limited ("Black Spade Capital"), a family office managing the private investments of Mr. Lawrence Ho, Chairman and Chief Executive of Melco International Development Limited, has announced it has invested and held shares in My Platform, a medical IT services platform.
| Mr. Jesse Ho, CEO of My Platform |
Founded in Hong Kong as a start-up, My Platform was launched as a brand-new medical management system by marrying IT with the concept of smart medical care. The result is a one-stop resources sharing platform with real-time access that connects the many stakeholders in the traditional healthcare ecosystem. The enormous growth potential of My Platform has attracted various investors, among them Black Spade Capital, whose investment affirms the value of My Platform.
Since its establishment in 2016, My Platform has been focusing on developing a simple and easy-to-use interface. With user experience in mind, the system allows users to master the clinic operating system in a short period of time. Be it a doctor, a medical group, an insurance company, a patient or the human resources department in an organization, users of My Platform can make use of the one-stop data management service to run analysis of different workflow from outpatient consultation to insurance claim. By constantly adding and customising system functionalities, not only does My Platform enhance user safety and operational efficiency, but it also saves time for performing diagnosis by doctors and healthcare practitioners. In response to the inconvenience and negative impact brought by the epidemic, My Platform has since been strengthening its service offerings and developing remote consultation services ("Telemedicine Services").
My Platform is one of the participating service providers under the D-Biz Programme launched by the Hong Kong SAR Government. It is committed to promoting a paperless medical work environment by transferring medical records and insurance information to cloud platform, thus allowing clinics to share resources. My Platform places great emphasis on data security so that users need not worry about any loss caused by computer malfunctioning. To shorten the lengthy process for medical insurance claims, My Platform enables doctors to directly connect with insurance companies such that both parties can choose their partners freely. By allowing real-time review and follow-up on claim status, the entire process becomes more transparent and the time lag from lodging a claim application to getting insurance compensation reduces significantly.
My Platform boasts a mature operation system which is recognized and appreciated by many doctors. In 2018, the well-known medical group Virtus Medical (managed by Dr Manson Fok, son of the late Mr. Henry Fok Ying-Tung, a vice chairman of the Chinese People's Political Consultative Conference (CPPCC)) took the lead to adopt the operation system of My Platform. At present, the system developed by My Platform is serving hundreds of general clinics, specialist clinics and radiology & imaging diagnostic centres in Hong Kong. It has also been adopted by reputable practitioners at Central Building, Hing Wai Building, Entertainment Building and the 15-storey Virtus Medical Tower (where the operation system of My Platform is adopted by practitioners in the entire building) in the Central district, as well as H Zentre (newly opened last year) and Hong Kong Pacific Center in Tsim Sha Tsui. In addition, the system of My Platform is also adopted by iRAD, one of the largest radiology & imaging diagnostic groups in Hong Kong, which further boosts the brand recognition of My Platform in the sector.
To date, the operation of My Platform has expanded to first-tier cities in the Mainland China such as Beijing and Shenzhen. With the support of the business development centre in Guangzhou, My Platform is capable of seizing business opportunities in mainland cities and providing a quality management system to local high-end clinics. Looking to the future, My Platform will strive to roll out its service to different cities in China to make its service portfolio more accessible to all stakeholders.
About Black Spade Capital Limited Black Spade Capital Limited is an established family office managing the private investments of Mr. Lawrence Ho. Headquartered in Hong Kong, its global portfolio consists of a wide spectrum of cross-border investments as it consistently seeks to add new projects and opportunities to its investment mix. Black Spade's investment strategy maximizes coverage of geographic regions and sectors whilst maintaining a portfolio of diversified asset classes, ranging from equity, fixed income, medical technology, leisure and culture, green energy, real estate to Pre-IPO investments.
Source: Black Spade Capital Limited Sectors: Daily Finance, Daily News
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025 Nov 22, 2024 11:00 JST
| NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth Nov 21, 2024 22:59 JST
| Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan Nov 21, 2024 15:35 JST
| Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP Nov 21, 2024 09:00 JST
| ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study Nov 20, 2024 23:05 JST
| Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center Nov 20, 2024 15:30 JST
| Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan Nov 20, 2024 11:51 JST
| Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements Nov 20, 2024 10:24 JST
| Kingsoft Announces 2024 Third Quarter Results Nov 19, 2024 18:54 JST
| NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System Nov 19, 2024 15:30 JST
| Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings Nov 19, 2024 09:02 JST
| CleverTap Recognized as a Strong Performer in Cross-Channel Marketing Hubs, Q4 2024 Report Nov 18, 2024 23:30 JST
| World's First Successful Trial of Quantum Tokens Created Using Quantum Technology Nov 18, 2024 17:29 JST
| Fujitsu and SAP Fioneer enter partnership to accelerate digital transformation in the insurance industry and deliver services that contribute to customers' sustainable business Nov 18, 2024 12:31 JST
| Expanding Possibilities with the Liquid Hydrogen-Powered GR Corolla in the Season Final Round Nov 18, 2024 09:25 JST
| COP29: Indonesian Special Envoy Hashim Djojohadikusumo Announces EUR 1,2 Billion Green Funding Nov 16, 2024 18:00 JST
| Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of LNG-Powered Roll-on/Roll-off Ship TRANS HARMONY EMERALD in Shimonoseki Nov 15, 2024 18:58 JST
| Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment) Nov 15, 2024 17:33 JST
| Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease Nov 15, 2024 14:31 JST
| Resorttrust Group and Mitsubishi Corporation Launch Joint Study in Medical Tourism Nov 15, 2024 12:32 JST
|
More Latest Release >>
|